Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × pazopanib × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 43 Genitourinary 43 Other solid neoplasm 13 Gastrointestinal 12 Gynecologic 11 Thoracic 10 Head & Neck 9 Breast 9 Tumor-Agnostic 6 Dermatologic 4 CNS 4 Endocrine 3 NET 2 Plasma cell 1 Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 671 Cytarabine 572 fludarabine 399 fludarabine phosphate 384 venetoclax 305 Methotrexate 297 Rituximab 283 Azacitidine 260 Busulfan 243 Whole-Body Irradiation 219 Etoposide 215 Filgrastim 213 Peripheral Blood Stem Cell Transplantation 210 Mycophenolic Acid 204 Tacrolimus 193 Dexamethasone 191 Granulocyte Colony-Stimulating Factor 181 Vincristine 173 Melphalan 171 Decitabine 162 Cyclosporine 145 Daunorubicin 137 Antilymphocyte Serum 136 Idarubicin 131 Imatinib Mesylate 127 Lenalidomide 116 Doxorubicin 109 Radiotherapy 108 Stem Cell Transplantation 106 Clofarabine 105

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01361334 2021-04-08

PAZOPANIB-AML

University Hospital Muenster

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡